Literature DB >> 26646118

Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Paul Nyquist1, Cynthia Bautista2, Draga Jichici3, Joseph Burns4, Sanjeev Chhangani5, Michele DeFilippis6, Fernando D Goldenberg7, Keri Kim8, Xi Liu-DeRyke9, William Mack10, Kim Meyer11.   

Abstract

The risk of death from venous thromboembolism (VTE) is high in intensive care unit patients with neurological diagnoses. This is due to an increased risk of venous stasis secondary to paralysis as well as an increased prevalence of underlying pathologies that cause endothelial activation and create an increased risk of embolus formation. In many of these diseases, there is an associated risk from bleeding because of standard VTE prophylaxis. There is a paucity of prospective studies examining different VTE prophylaxis strategies in the neurologically ill. The lack of a solid evidentiary base has posed challenges for the establishment of consistent and evidence-based clinical practice standards. In response to this need for guidance, the Neurocritical Care Society set out to develop and evidence-based guideline using GRADE to safely reduce VTE and its associated complications.

Entities:  

Keywords:  Intracranial hemorrhage; Pulmonary embolus; Stroke; Subarachnoid hemorrhage; Traumatic brain injury; Venous thrombus

Mesh:

Year:  2016        PMID: 26646118     DOI: 10.1007/s12028-015-0221-y

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  140 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Safety of mini-dose heparin administration for neurosurgical patients.

Authors:  H G Barnett; J R Clifford; R C Llewellyn
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

3.  Deaths: final data for 2008.

Authors:  Arialdi M Miniño; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2011-12-07

4.  PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

Authors:  J R Perry; J A Julian; N J Laperriere; W Geerts; G Agnelli; L R Rogers; M G Malkin; R Sawaya; R Baker; A Falanga; S Parpia; T Finch; M N Levine
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

5.  What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.

Authors:  Cumara B O'Carroll; Dan J Capampangan; Maria I Aguilar; Thomas P Bravo; Charlene R Hoffman-Snyder; Dean M Wingerchuk; Kay E Wellik; Bart M Demaerschalk
Journal:  Neurologist       Date:  2011-07       Impact factor: 1.398

Review 6.  Thromboembolic disease in spinal surgery: a systematic review.

Authors:  Michael P Glotzbecker; Christopher M Bono; Kirkham B Wood; Mitchell B Harris
Journal:  Spine (Phila Pa 1976)       Date:  2009-02-01       Impact factor: 3.468

7.  A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral haemorrhage.

Authors:  Mohammad Wasay; Saqibuddin Khan; Khawaja S Zaki; Bhojo A Khealani; Ayeesha Kamal; Iqbal Azam; Ismail A Khatri
Journal:  J Pak Med Assoc       Date:  2008-07       Impact factor: 0.781

8.  Thromboembolism in patients with high-grade glioma.

Authors:  J F Quevedo; J C Buckner; J L Schmidt; R P Dinapoli; J R O'Fallon
Journal:  Mayo Clin Proc       Date:  1994-04       Impact factor: 7.616

9.  Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.

Authors:  M Margaret Knudson; Danagra G Ikossi; Linda Khaw; Diane Morabito; Larisa S Speetzen
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

10.  The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Authors:  David G Sherman; Gregory W Albers; Christopher Bladin; Cesare Fieschi; Alberto A Gabbai; Carlos S Kase; William O'Riordan; Graham F Pineo
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

View more
  27 in total

1.  [Modern principles of neurocritical care].

Authors:  Julian Bösel
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

2.  Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.

Authors:  Kevin Betthauser; Hannah Pope; Mollie Gowan; Theresa Human
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

3.  Emergency Neurological Life Support: Intracerebral Hemorrhage.

Authors:  J Claude Hemphill; Arthur Lam
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

4.  Risk of Venous Thromboembolism in Patients with Large Hemispheric Infarction Undergoing Decompressive Hemicraniectomy.

Authors:  Nohra Chalouhi; Badih Daou; Fred Rincon; Maria Montano; Anthony Kent; Kaitlyn Barkley; Robert M Starke; Stavropoula Tjoumakaris; David Hasan; Richard Dalyai; Robert Rosenwasser; Pascal Jabbour
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

5.  Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial.

Authors: 
Journal:  Neurosurgery       Date:  2019-03-01       Impact factor: 4.654

Review 6.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

7.  Venous Thromboembolism Prophylaxis in Neurocritical Care Patients: Are Current Practices, Best Practices?

Authors:  K M Sauro; A Soo; A Kramer; P Couillard; J Kromm; D Zygun; D J Niven; S M Bagshaw; H T Stelfox
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

8.  A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.

Authors:  Henry T Stelfox; Rebecca Brundin-Mather; Andrea Soo; Jeanna Parsons Leigh; Daniel J Niven; Kirsten M Fiest; Christopher James Doig; Danny J Zuege; Barry Kushner; Fiona Clement; Sharon E Straus; Deborah J Cook; Sean M Bagshaw; Khara M Sauro
Journal:  Intensive Care Med       Date:  2019-02-01       Impact factor: 17.440

9.  Impact of practice change in reducing venous thromboembolism in neurocritical overweight patients: 2008-2014.

Authors:  Sophie Samuel; Suhas Bajgur; Jude P Savarraj; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

10.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.